Evidence map›Paper›PMID 33154160›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Evolution of insulin at the edge of foldability and its medical implications.

Nischay K Rege, Ming Liu, Yanwu Yang, Balamurugan Dhayalan, Nalinda P Wickramasinghe, Yen-Shan Chen, Leili Rahimi, Huan Guo, Leena Haataja, Jinhong Sun and 4 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Stabilization of a protein by a single halogen-based aromatic amplifier.Protein science : a publication of the Protein Society · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Insulin Therapy for the Management of Diabetes Mellitus: A Narrative Review of Innovative Treatment Strategies.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2023
    Review
  11. Article
  12. Review
  13. Deep Eutectic Solvents for Subcutaneous Delivery of Protein Therapeutics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Nischay K RegeDepartment of Biochemistry, Case Western Reserve University, Cleveland, OH 44106.ORCID 0000-0002-3858-9530
Ming LiuDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, 300052 Tianjin, China.ORCID 0000-0003-2665-4072
Yanwu YangDepartment of Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202.ORCID 0000-0002-4832-2987
Balamurugan DhayalanDepartment of Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202.ORCID 0000-0001-6002-1207
Nalinda P WickramasingheDepartment of Biochemistry, Case Western Reserve University, Cleveland, OH 44106.ORCID 0000-0002-8700-2775
Yen-Shan ChenDepartment of Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202.ORCID 0000-0003-4746-6636
Leili RahimiDepartment of Biochemistry, Case Western Reserve University, Cleveland, OH 44106.ORCID 0000-0002-3908-8324
Huan GuoDivision of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, MI 48105.
Leena HaatajaDivision of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, MI 48105.ORCID 0000-0003-3701-4679
Jinhong SunDivision of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, MI 48105.
Faramarz Ismail-BeigiDepartment of Biochemistry, Case Western Reserve University, Cleveland, OH 44106.ORCID 0000-0002-1154-5482
Nelson B PhillipsDepartment of Biochemistry, Case Western Reserve University, Cleveland, OH 44106.
Peter ArvanDivision of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, MI 48105.ORCID 0000-0002-4007-8799
Michael A WeissDepartment of Biochemistry, Case Western Reserve University, Cleveland, OH 44106; weissma@iu.edu.ORCID 0000-0003-1325-1610
Case Western Reserve University · USUniversity of Michigan · USIndiana University School of Medicine

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WILLIAM H HERMAN · 2013 to 2026
$24.3M
Proinsulin Trafficking for Insulin BiosynthesisR01DK048280 · NIDDK · YESHIVA UNIVERSITY · PI ARVAN, PETER · 1994 to 2024
$10.5M
Non-Standard Protein Design in Molecular Endocrinology: Insulin and GlucagonR01DK040949 · NIDDK · UNIVERSITY OF CHICAGO · PI CHERRINGTON, ALAN D, GEORGIADIS, MILLIE M · 1989 to 2024
$8.4M
How mutations in proinsulin cause diabetes: a protein-misfolding diseaseR01DK069764 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI ARVAN, PETER, KENT, STEPHEN B.H. · 2004 to 2014
$3.5M
Development and characterization of ultra-stable insulin analogs for novel therapeutic useF30DK112644 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI REGE, NISCHAY KIRAN · 2016 to 2020
$179k
NIDDK NIH HHS F30 DK112644NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK040949NIDDK NIH HHS R01 DK048280NIDDK NIH HHS R01 DK069764NIGMS NIH HHS T32 GM007250
6 · The paper itself

Abstract

Proteins have evolved to be foldable, and yet determinants of foldability may be inapparent once the native state is reached. Insight has emerged from studies of diseases of protein misfolding, exemplified by monogenic diabetes mellitus due to mutations in proinsulin leading to endoplasmic reticulum stress and β-cell death. Cellular foldability of human proinsulin requires an invariant Phe within a conserved crevice at the receptor-binding surface (position B24). Any substitution, even related aromatic residue Tyr

Indexed as

Amino Acid SubstitutionAnimalsCell LineCell Line, TumorDiabetes MellitusDisulfidesGene Regulatory NetworksHEK293 CellsHumansInsulinInsulin-Secreting CellsMCF-7 CellsProinsulinProtein BindingProtein FoldingRatsDisulfidesInsulinProinsulinReceptor, Insulinevolutionary medicinefolding efficiencyprotein foldingprotein structureunfolded protein response

Identifiers

PMID33154160
PMCPMC7703552
OpenAlexW3096196522

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.